Related Experiment Videos
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development
The Journal of General Virology
|October 1, 1985
Abstract:
Serial mutagenesis with 5-fluorouracil has been employed to derive an attenuated strain of Rift Valley fever virus for use as a live virus vaccine.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quality Assurance in Multi-Modality Oesophago-Gastric Cancer Clinical Trials: Past, Present and Future Perspectives.
Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2024
Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: A systematic review by the PIPAC UK collaborative.
Critical reviews in oncology/hematology·2022
Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.
Human vaccines & immunotherapeutics·2019
Optogenetic and temperature-dependent modulation of vesicular stomatitis virus polymerase activity by an intramolecular dimerizer.
The Journal of general virology·2026
Genomic characterization of Lao Mobatvirus strains reveals host-associated clustering in Southeast Asian bats.
The Journal of general virology·2026
Bluetongue virus: current perspectives on characterisation and the need to formalise nomenclature in an era of rapidly evolving technology.
The Journal of general virology·2026
Core protein mutations are key determinants of hepatitis B virus replication during the hepatitis B e antigen-negative stage.
The Journal of general virology·2026
From family trials to genomic mate allocation: statistical and genomic strategies to accelerate sugarcane genetic improvement.
TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2026
Indigenous Fruit-Derived Lactic Acid Bacteria with Probiotic Potential and Angiotensin-Converting Enzyme I Inhibitory Activity.
Probiotics and antimicrobial proteins·2026